MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Aura Biosciences, Inc. (NASDAQ: AURA)*
Organization & Developments: Aura Biosciences
Parents
Aura Biosciences, Inc. (NASDAQ: AURA)*
Children
2024: Aura Biosciences Reports Positive Phase 2 End of Study
2024: Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58%
2024: Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value
2024: Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company
2024: Aura's virus-based drug regimen eradicates tumors in 4 out of 5 low-grade bladder cancer patients
2024: We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate
2026: Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer
Jumps
Finance & Acquisitions: Aura Biosciences
Key People: Aura Biosciences